enow.com Web Search

  1. Ads

    related to: abbvie work from home

Search results

  1. Results from the WOW.Com Content Network
  2. AbbVie - Wikipedia

    en.wikipedia.org/wiki/AbbVie

    In June, Abbvie acquired TeneoOne and its lead compound TNB-383B. The compound is a BCMA-targeting immunotherapeutic for relapsed or refractory multiple myeloma. [30] In March 2022, AbbVie acquired Syndesi Therapeutics for up to $1 billion and its portfolio of novel modulators of the synaptic vesicle protein 2A and lead compound SDI-118.

  3. Find Remote Jobs at These 41 Work-From-Home Companies - AOL

    www.aol.com/finance/remote-jobs-32-home...

    41 Companies With Work-From-Home Jobs. We do our homework on companies before sharing them with our readers by vetting them. Here’s a list of work-from-home companies with regular job opportunities.

  4. The 2021 Working Mothers of the Year's Best Advice for ... - AOL

    www.aol.com/2021-working-mothers-years-best...

    AbbVie provides amazing opportunities to connect with colleagues across the company to network, engage with, and share personal experiences. ... While my work and home life remain blended, I ...

  5. Where Will AbbVie Be in 5 Years? - AOL

    www.aol.com/finance/where-abbvie-5-years...

    Most pharmaceutical businesses are slow-moving by nature due to the lengthy amount of time it takes to develop a new medicine, and AbbVie (NYSE: ABBV) is no exception. In the next five years ...

  6. Abbott Laboratories - Wikipedia

    en.wikipedia.org/wiki/Abbott_Laboratories

    Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Green Oaks, Illinois, United States.The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products.

  7. Pharmacyclics - Wikipedia

    en.wikipedia.org/wiki/Pharmacyclics

    In March 2015, Chicago-based biopharmaceutical firm AbbVie announced it would acquire Pharmacyclics, as well as its lead anti-cancer compound ibrutinib (Imbruvica) for $21 billion. As part of the deal, AbbVie will pay $261.25 per share in a mixture of both cash and AbbVie equity. [6] The merger is expected to close in mid-2015. [7]

  1. Ads

    related to: abbvie work from home